Page last updated: 2024-12-05

4-hydroxybenzophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxybenzophenone, also known as benzophenone-4, is an organic compound used as a UV absorber in sunscreen and cosmetics. It absorbs UV radiation, protecting the skin from sun damage. 4-hydroxybenzophenone is synthesized via a Friedel-Crafts acylation reaction between phenol and benzoyl chloride. Research on 4-hydroxybenzophenone focuses on its effectiveness as a sunscreen ingredient, its potential phototoxicity and endocrine disruption, and its environmental impact. Studies have shown that 4-hydroxybenzophenone can penetrate the skin and accumulate in the body, raising concerns about its long-term health effects. Its wide use and potential environmental implications have led to ongoing research and regulatory scrutiny.'

4-hydroxybenzophenone: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14347
CHEMBL ID194487
CHEBI ID34421
SCHEMBL ID124916
MeSH IDM0082381

Synonyms (59)

Synonym
BIDD:ER0013
nsc1887
4'-hydroxybenzophenone
p-hydroxybenzophenone
4-benzoylphenol
1137-42-4
p-benzoylphenol
benzophenone, 4-hydroxy-
4-hydroxybenzophenone
methanone, (4-hydroxyphenyl)phenyl-
nsc-1887
nsc 1887
ai3-00862
einecs 214-507-1
(4-hydroxyphenyl)phenylmethanone
4-hydroxy-benzophenone
(4-hydroxyphenyl)(phenyl)methanone
inchi=1/c13h10o2/c14-12-8-6-11(7-9-12)13(15)10-4-2-1-3-5-10/h1-9,14
4-hydroxybenzophenone, 98%
STK045122
(4-hydroxyphenyl)-phenylmethanone
CHEMBL194487 ,
chebi:34421 ,
H0222
AKOS000119744
A803085
NCGC00248965-01
unii-04r2lws0ms
04r2lws0ms ,
tox21_201229
dtxcid3016684
dtxsid5036684 ,
cas-1137-42-4
NCGC00258781-01
bdbm50410491
FT-0618700
4-hydroxyphenyl phenyl ketone
AB00376867-03
SCHEMBL124916
1-(4-hydroxyphenyl)-1-phenylmethanone
n-(4-hydroxylphenyl)-n'-phenylurea
4-hydroxy-benzphenone
4-hydroxy benzophenone
4-hydroxylbenzophenone
(4-hydroxy-phenyl)-phenyl-methanone
(4-hydroxyphenyl)-phenyl-methanone
(4-hydroxyphenyl)(phenyl)methanone #
(4-hydroxy-phenyl)-phenylmethanone
W-108613
PS-8242
mfcd00002355
F0001-0279
NCGC00248965-02
F11203
Q27116055
EN300-21521
CS-W015653
Z104500636
PD065561

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results indicated that most TPs may be less toxic than their parent chemicals, but some may be more toxic, and that intestinal toxicity of TPs may be more obvious than blood toxicity."( A novel two-dimensional liquid-chromatography method for online prediction of the toxicity of transformation products of benzophenones after water chlorination.
Li, J; Ma, LY; Shi, ZG; Xu, L, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzophenonesAny aromatic ketone in which the carbonyl group is bonded to 2 phenyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency80.55110.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency26.11040.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency18.73000.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency19.64290.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743053; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency12.33370.000657.913322,387.1992AID1259377; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency32.34190.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency43.76170.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency36.32480.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency46.69060.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency61.81500.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.41900.000229.305416,493.5996AID1259244; AID1259383; AID743069; AID743075; AID743077; AID743078; AID743079; AID743080; AID743091
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency21.93280.001723.839378.1014AID743083
Histone H2A.xCricetulus griseus (Chinese hamster)Potency57.29270.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency12.33370.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency61.81500.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency61.81500.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency61.81500.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)181.97000.00101.979414.1600AID255211
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID763098Leishmanicidal activity against promastigote form of Leishmania amazonensis MHOM/BR/71973/M2269 after 72 hrs by cell counting2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones.
AID684467Inhibition of apolipoprotein E production in human CCF-STTG1 cells at 10 uM after 24 hrs by ELISA relative to vehicle-treated control2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production.
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
AID763097Cytotoxicity against mouse peritoneal macrophages after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones.
AID1413263Inhibition of full length Escherichia coli DNA gyrase ATPase activity at 1 mM measured for 20 mins by lactate dehydrogenase assay relative to control2018MedChemComm, Oct-01, Volume: 9, Issue:10
Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.00)18.7374
1990's0 (0.00)18.2507
2000's3 (15.00)29.6817
2010's13 (65.00)24.3611
2020's3 (15.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.43 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index73.13 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]